(UroToday.com) The 2025 European Association of Urology (EAU) Annual Congress held in Madrid, Spain, between March 21 st and 24 th 2025, was host to a thematic session on hot topics in the management ...

The 34rd World Congress of Endourology (WCE) held in Conjunction with the South African Urological Association (SAUA) Meeting in 2016 was held in Cape Town, South Africa from November 8th-12th, 2016.

PSMA and Beyond 2025 antibody drug development (ADC) in prostate cancer, ADC program in advance prostate cancer, PSMA expression, ...

ASCO 2025, prostate cancer, radioligand therapy (RLT), Radioligand Therapies in Prostate Cancer, Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography (PSMA-PET), 177Lu-PSMA-617.

SNMMI 2025, PROSTATE CANCER, Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography (PSMA-PET), Artificial Intelligence-based Risk Score for Prostate Cancer on PSMA PET/CT.

ASCO 2025, Nivolumab plus ipilimumab vs sunitinib, casdatifan plus cabozantinib, Hypoxia-inducible factor-2α (HIF-2α) inhibitor belzutifan, ALLO-316 in advanced clear cell renal cell carcinoma (ccRCC) ...

AUA 2025, penile fracture, AUA Guidelines for penile fractures, intralesional Collagenase Clostridium Histolyticum therapy (CCH), Peyronie’s Disease (PD), IMPRESS Trials.

ASCO GU 2025, metastatic castration resistant prostate cancer (mCRPC), Precision Diagnostics in Prostate Cancer Treatment (PREDICT): PREDICT trial, Alliance A032102, H3 lysine 27 methylation (H3K27me) ...